NVO

Novo Nordisk A/SC

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-20

View Chart

Peers tracked

U.S. public peers

Grade Position

In line

vs peer average

NVO vs peer average

55/100

NVO vs. peer average (C vs. C)

Grade spread

B 3 · C 2 · D 4 · F 1

Graded peers loaded

Coverage

10 graded

100% of tracked

Peer overview

LLY is the first available peer comparator.

Closest commercial obesity and diabetes competitor; the cleanest read-through on U.S. pricing, access, and category share for Novo's Wegovy franchise.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerLLYEli Lilly and

NVO

Novo Nordisk A/S

LLY

Eli Lilly and

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Mixed

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs LLY

NVO / LLY

Grade Position

In line

NVO vs. peer average (C vs. C)

55/100

Momentum

NVO

Value

LLY

Sentiment

LLY

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs NVO

LLY

80/100

-1

AMGN

40/100

VKTX

80/100

-1

TMO

Thermo Fisher Scientific Inc Common

80/100

-1

AZN

AstraZeneca PLC Common

20/100

LLY is the first peer returned for this comparison set.